WallStSmart
BMGL

Basel Medical Group Ltd Ordinary Shares

NASDAQ: BMGL · HEALTHCARE · MEDICAL CARE FACILITIES

$0.76
+12.27% today

Updated 2026-06-05

Market cap
$12.32M
P/E ratio
P/S ratio
1.09x
EPS (TTM)
$-0.45
Dividend yield
52W range
$0 – $5
Volume
0.7M

Basel Medical Group Ltd Ordinary Shares (BMGL) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2022202320242025
Total assets$16.85M$15.38M$16.31M$16.85M
Cash & equivalents$1.56M$1.22M$1.95M$2.98M
Current assets$15.67M$14.77M$16.17M$13.12M
Total liabilities$13.14M$9.89M$8.75M$11.99M
Current liabilities$7.19M$6.47M$7.16M$10.69M
Long-term debt$5.31M$3.40M$1.58M
Shareholder equity$3.71M$5.49M$7.56M$4.86M
Retained earnings$3.71M$5.49M$7.56M$-4.40M
Accounts receivable$13.88M$13.33M$12.44M$2.49M
Inventory$69826.00$94601.00$72030.00$376291.00
Goodwill

Frequently asked questions

What is Basel Medical Group Ltd Ordinary Shares's revenue?

Basel Medical Group Ltd Ordinary Shares's trailing twelve-month revenue is $11.35M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is BMGL?

In its most recent fiscal year, BMGL ran a gross margin of 77.68%, an operating margin of -19.28%, and a net margin of -106.78%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does BMGL generate?

BMGL produced $-4.40M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is BMGL's balance sheet healthy?

BMGL holds $2.98M in cash and equivalents against — in long-term debt, on $4.86M of shareholder equity. That debt is best read against the cash flow the business throws off each year.